The epigenetically active small chemical N-methyl pyrrolidone (NMP) prevents estrogen depletion induced osteoporosis. 2015

Bebeka Gjoksi, and Chafik Ghayor, and Barbara Siegenthaler, and Nisarat Ruangsawasdi, and Marcy Zenobi-Wong, and Franz E Weber
University Hospital, Division of Cranio-Maxillofacial and Oral Surgery and University of Zurich, Center of Dental Medicine, Oral Biotechnology & Bioengineering, Plattenstrasse 11, 8032 Zürich, Switzerland; Cartilage Engineering+Regeneration Laboratory, ETH Zurich, Zurich, Switzerland.

Currently, there are several treatments for osteoporosis however; they all display some sort of limitation and/or side effects making the need for new treatments imperative. We have previously demonstrated that NMP is a bioactive drug which enhances bone regeneration in vivo and acts as an enhancer of bone morphogenetic protein (BMP) in vitro. NMP also inhibits osteoclast differentiation and attenuates bone resorption. In the present study, we tested NMP as a bromodomain inhibitor and for osteoporosis prevention on ovariectomized (OVX) induced rats while treated systemically with NMP. Female Sprague-Dawley rats were ovariectomized and weekly NMP treatment was administrated 1 week after surgery for 15 weeks. Bone parameters and related serum biomarkers were analyzed. 15 weeks of NMP treatment decreased ovariectomy-induced gained weight in average by 43% and improved bone mineral density (BMD) and bone volume over total volume (BV/TV) in rat femur on average by 25% and 41% respectively. Moreover, mineral apposition rate and bone biomarkers of bone turnover in the treatment group were at similar levels with those of the Sham group. Due to the function of NMP as a low affinity bromodomain inhibitor and its mechanism of action involving osteoblasts/osteoclasts balance and inhibitory effect on inflammatory cytokines, NMP is a promising therapeutic compound for the prevention of osteoporosis.

UI MeSH Term Description Entries
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D010052 Ovariectomy The surgical removal of one or both ovaries. Castration, Female,Oophorectomy,Bilateral Ovariectomy,Bilateral Ovariectomies,Castrations, Female,Female Castration,Female Castrations,Oophorectomies,Ovariectomies,Ovariectomies, Bilateral,Ovariectomy, Bilateral
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell

Related Publications

Bebeka Gjoksi, and Chafik Ghayor, and Barbara Siegenthaler, and Nisarat Ruangsawasdi, and Marcy Zenobi-Wong, and Franz E Weber
September 1992, Contact dermatitis,
Bebeka Gjoksi, and Chafik Ghayor, and Barbara Siegenthaler, and Nisarat Ruangsawasdi, and Marcy Zenobi-Wong, and Franz E Weber
September 2018, Medical science monitor : international medical journal of experimental and clinical research,
Bebeka Gjoksi, and Chafik Ghayor, and Barbara Siegenthaler, and Nisarat Ruangsawasdi, and Marcy Zenobi-Wong, and Franz E Weber
December 2007, Toxicology letters,
Bebeka Gjoksi, and Chafik Ghayor, and Barbara Siegenthaler, and Nisarat Ruangsawasdi, and Marcy Zenobi-Wong, and Franz E Weber
September 2018, The journal of physical chemistry. B,
Bebeka Gjoksi, and Chafik Ghayor, and Barbara Siegenthaler, and Nisarat Ruangsawasdi, and Marcy Zenobi-Wong, and Franz E Weber
October 2015, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz,
Bebeka Gjoksi, and Chafik Ghayor, and Barbara Siegenthaler, and Nisarat Ruangsawasdi, and Marcy Zenobi-Wong, and Franz E Weber
May 2003, International archives of occupational and environmental health,
Bebeka Gjoksi, and Chafik Ghayor, and Barbara Siegenthaler, and Nisarat Ruangsawasdi, and Marcy Zenobi-Wong, and Franz E Weber
August 1987, Fundamental and applied toxicology : official journal of the Society of Toxicology,
Bebeka Gjoksi, and Chafik Ghayor, and Barbara Siegenthaler, and Nisarat Ruangsawasdi, and Marcy Zenobi-Wong, and Franz E Weber
January 2016, The Journal of toxicological sciences,
Bebeka Gjoksi, and Chafik Ghayor, and Barbara Siegenthaler, and Nisarat Ruangsawasdi, and Marcy Zenobi-Wong, and Franz E Weber
April 1997, Occupational and environmental medicine,
Bebeka Gjoksi, and Chafik Ghayor, and Barbara Siegenthaler, and Nisarat Ruangsawasdi, and Marcy Zenobi-Wong, and Franz E Weber
September 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Copied contents to your clipboard!